(19)
(11) EP 4 153 635 A1

(12)

(43) Date of publication:
29.03.2023 Bulletin 2023/13

(21) Application number: 21809551.1

(22) Date of filing: 21.05.2021
(51) International Patent Classification (IPC): 
C07K 16/32(2006.01)
A61K 38/17(2006.01)
C07K 14/705(2006.01)
A61P 35/00(2006.01)
C12N 5/0783(2010.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/32; A61P 35/00; C07K 14/4748; C07K 14/71; C07K 2317/92; C07K 2317/622; C07K 2319/03; C07K 2319/33; C07K 2317/565; C07K 2317/73; A61K 35/17; A61K 38/00
(86) International application number:
PCT/KR2021/006361
(87) International publication number:
WO 2021/235894 (25.11.2021 Gazette 2021/47)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 22.05.2020 US 202016881650

(71) Applicants:
  • GC Cell Corporation
    Gyeonggi-do 16924 (KR)
  • AbClon Inc.
    Seoul 08381 (KR)

(72) Inventors:
  • LEE, Jong-Seo
    Seongnam-si Gyeonggi-do 13473 (KR)
  • KIM, Kyu-Tae
    Goyang-si Gyeonggi-do 10551 (KR)
  • LEE, Young-Ha
    Seoul 04753 (KR)
  • HWANG, In-Sik
    Incheon 21059 (KR)
  • KO, Bong-Kook
    Seoul 08766 (KR)
  • CHOI, Eunji
    Yongin-si Gyeonggi-do 16924 (KR)
  • KIM, You-Sun
    Yongin-si Gyeonggi-do 16924 (KR)
  • KIM, Jeongmin
    Yongin-si Gyeonggi-do 16924 (KR)
  • JUNG, Miyoung
    Yongin-si Gyeonggi-do 16924 (KR)
  • LIM, Hoyong
    Yongin-si Gyeonggi-do 16924 (KR)
  • CHO, Sungyoo
    Yongin-si Gyeonggi-do 16924 (KR)

(74) Representative: Fish & Richardson P.C. 
Highlight Business Towers Mies-van-der-Rohe-Straße 8
80807 München
80807 München (DE)

   


(54) ANTI-HER2 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, AND CHIMERIC ANTIGEN RECEPTOR COMPRISING SAME